Intermediate-term results after partial left ventriculectomy for end-stage dilated cardiomyopathy: is there a survival benefit?

Background: The mortality of congestive heart failure remains high despite advances in medical therapy. Partial left ventriculectomy (PLV) has been advocated as a surgical alternative for select patients with dilated cardiomyopathy.

Methods: A prospective clinical trial of PLV for patients with end-stage idiopathic dilated cardiomyopathy was performed.